Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2008
11/20/2008WO2008138536A2 Antibody directed to g protein coupled receptors (gpcr)
11/20/2008WO2008138475A1 Use of crmp1 as a marker for chronic psychiatric illnesses and monoclonal antibodies against crmp1
11/20/2008WO2008138189A1 Use of cthrc1 in diagnosing cancer of liver
11/20/2008WO2008119882A3 Screening methods based on human adam12 polypeptide and binding agents thereof
11/20/2008WO2008118356A3 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
11/20/2008WO2008115470A3 Hox-gene expression as a biomarker for igf-1r therapeutics
11/20/2008WO2008112201A3 Lysophosphatidic acid receptor targeting for lung disease
11/20/2008WO2008112003A3 Targeted binding agents directed to pdgfr-alpha and uses thereof
11/20/2008WO2008109463A3 Red-shifted luciferase
11/20/2008WO2008108910A3 Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy
11/20/2008WO2008106134A3 Engineered anti-il-23r antibodies
11/20/2008WO2008104805A3 Proteins
11/20/2008WO2008095110A3 Compositions and methods for detecting cancers in a subject
11/20/2008WO2008093280A3 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen
11/20/2008WO2008091740A3 Polyelectrolyte precipitation and purification of antibodies
11/20/2008WO2008074839A3 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
11/20/2008WO2008070344A3 Compositions and methods for binding sphingosine-1-phosphate
11/20/2008WO2008070137A3 Interferon alpha-induced pharmacodynamic markers
11/20/2008WO2008060331A9 Antibodies to sars coronavirus
11/20/2008WO2008058706A3 Enterococcus faecalis and/or enterococcus faecium antigen
11/20/2008WO2008057171A3 4-1 bb ligand in inflammatory diseases
11/20/2008WO2008048689A3 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
11/20/2008WO2008008284A3 Cancer biomarkers and methods of use threof
11/20/2008WO2007130646A3 Hcv coreceptor and methods of use thereof
11/20/2008WO2007117490A3 Antibody purification
11/20/2008WO2007112193A3 Camptothecin-binding moiety conjugates
11/20/2008WO2007056539A3 Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
11/20/2008WO2004030615A8 Compositions and methods for the diagnosis and treatment of tumor
11/20/2008US20080289057 Sperm factor sequences
11/20/2008US20080289056 Aldolases, nucleic acids encoding them; improving thermal stability of enzyme; biosynthesis of atorvastatin, rosuvastatin, fluvastatin starting from e.g. acetaldehyde and chloroacetaldehyde, using enzyme 2-deoxyribose-5-phosphate aldolase (DERA) to form pyran intermediate
11/20/2008US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods
11/20/2008US20080287665 CANINE IgG NUCLEIC ACID MOLECULES
11/20/2008US20080287658 Docetaxel Immunoassay
11/20/2008US20080287657 Modified immunoglobulin receptor for use as enhanced indicator tool immunological detection; protein detection
11/20/2008US20080287388 Human G-Protein Coupled Receptor
11/20/2008US20080287386 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
11/20/2008US20080287364 Bitter Taste Receptors
11/20/2008US20080287363 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11
11/20/2008US20080287353 Peptides and proteins for early liver development and antibodies thereto
11/20/2008US20080287309 Methods for Discovering Antibodies Specific to Cancer Cells and Antibodies Discovered Thereby
11/20/2008US20080287304 Mixture of at Least Two Fusion Proteins as Well as Their Production and Use
11/20/2008US20080286877 Displacement assay for detection of small molecules
11/20/2008US20080286832 Methods for Obtaining Optically Active Epoxides and Vicinal Diols From 2,2-Disubstituted Epoxides
11/20/2008US20080286821 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2008US20080286819 Reagents, Methods and Systems for Selecting a Cytotoxic Antibody or Variant Thereof
11/20/2008US20080286814 Biomarkers for Detecting Cancer
11/20/2008US20080286813 Antibody specific for mutant presenilin 1 and method of use thereof
11/20/2008US20080286805 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
11/20/2008US20080286804 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
11/20/2008US20080286781 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
11/20/2008US20080286779 Host Cells Containing Multiple Integrating Vectors
11/20/2008US20080286755 Immunoglobin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same
11/20/2008US20080286290 Anti-Cd14 Antibody Fusion Protein
11/20/2008US20080286289 Use of B Cell Expansion Agents in Generating Antibodies
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286285 Methods for Treating Vascular Disease
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286283 Treatment of cancer with antibodies to costimulating polypeptide of T cells
11/20/2008US20080286281 Cd25 binding molecules for the use in the treatment of manifestations of rejection in transplantation
11/20/2008US20080286280 Stable Lyophilized Pharmaceutical Preparations of Monoclonal or polyclonal antibodies
11/20/2008US20080286277 Monoclonal antibody comprising specificity determining residues for targeting tumor cells for destruction
11/20/2008US20080286276 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
11/20/2008US20080286275 Antigen Binding Proteins Directed Against Scavenger Receptor B1 that Inhibit Hcv Replication
11/20/2008US20080286274 Vector for Efficient Selection and/or Maturation of an Antibody and Uses Thereof
11/20/2008US20080286270 Stabilized liquid anti-RSV antibody formulations
11/20/2008US20080286269 Anti-alpha(v)beta(6) antibodies and uses thereof
11/20/2008US20080286198 Novel anti-IGF-IR antibodies and uses thereof
11/20/2008US20080286197 Antibody recognizing misfolded proteins that can be assigned specifically to one of the diseases
11/20/2008DE102007023183A1 Verwendung von Autoantikörpern gegen CD28 als prognostischer Marker beim malignen Melanom Use of auto-antibodies to CD28 as a prognostic marker in malignant melanoma
11/20/2008DE102007022669A1 Verwendung von CRMP1 als Marker für chronisch psychiatrische Erkrankungen Use of CRMP1 as a marker for chronic psychiatric disorders
11/20/2008CA2687266A1 Means and methods for enhancing differentiation of haematopoietic progenitor cells
11/20/2008CA2687147A1 H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance
11/20/2008CA2686238A1 Antibody directed to g protein coupled receptors (gpcr)
11/20/2008CA2680344A1 Humaneered anti-factor b antibody
11/20/2008CA2670315A1 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
11/20/2008CA2668208A1 Hybrid immunoglobulins with moving parts
11/19/2008EP1992696A1 Circovirus sequences associated with porcine wasting disease (PWD)
11/19/2008EP1992695A2 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
11/19/2008EP1992692A1 Immunoglobulin affinity ligand
11/19/2008EP1992644A1 Antibodies against CCR4 and its fragments
11/19/2008EP1992643A2 Compositions and methods for the diagnosis and treatment of tumor
11/19/2008EP1992640A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
11/19/2008EP1992636A2 Process for correction of a disulfide misfold in Fc molecules
11/19/2008EP1991872A1 Methods for diagnosing pancreatic cancer using reg4 protein
11/19/2008EP1991693A1 Method for differentiating between multiple sclerosis subtypes
11/19/2008EP1991689A1 Process for the production of a fine chemical
11/19/2008EP1991585A2 Humanized anti-ghrelin antibodies
11/19/2008EP1991584A1 Antibodies against human il-22 and uses therefor
11/19/2008EP1991583A1 Thymic stromal lymphopoietin (tslp) antibodies and uses thereof
11/19/2008EP1991582A2 Antibodies against secreted frizzled related protein-4 (sfrp-4)
11/19/2008EP1991581A2 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
11/19/2008EP1991580A2 Generation of heavy-chain only antibodies in transgenic animals
11/19/2008EP1991579A1 Growth inhibitory composition against pathogenic bacteria of meat based food stuff comprising igy
11/19/2008EP1991267A2 Methods of treating inflammatory and autoimmune diseases with natalizumab
11/19/2008EP1991261A2 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain
11/19/2008EP1545607B1 Allergy vaccines
11/19/2008EP1513553B1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
11/19/2008EP1503781B1 Treatment for reduction of body weight gain
11/19/2008EP1495146B1 Antibody libraries
11/19/2008EP1428537B1 Stabilized preparations containing antibody
1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 1494